RCE recce pharmaceuticals ltd

3.33%

31.0¢

RCE Charts, page-1200

First 1200 Last

Share
Profile

Follow
Gitmo

2,031 Posts.

312

09/06/21

08:41

Post #: 53730552
Share

Originally posted by andrewk65: ↑

It will be interesting to see how things develop from here. The timelines in latest update were certainly a lot longer that I ever expected. I guess nothing happens fast. On the plus side the burns trial has clearly started now which I would assume at least one patient is currently being dosed and the proposed dosing schedule was 14 days I believe. So one would assume data may possibly be available very shortly if not already. I guess it just depends what they chose to share. The longer they stay quiet the more holders may become nervous I suppose, myself included unfortunately.

For me it feels like I would just like some further confirmation this compound is safe in humans. To date we have the doctors self dose and sinusitis patient, which are both a great start.

If we could get good data on one or two initial burns patients that would make the wait for final data a lot less stressful.
on the plus side great financial position and it looks like a lot of ongoing costs are being listed as research and development which attract the generous rebates from government and possibly overseas sources for any research conducted off shore.

Expand

Don't stress. They indicated that interim data on the burns trial will be released. Lots of work going on in the background. Don't equate stagnant share price for stagnant progress. The bot action is annoying but I prefer to focus on what the company says not what the share price does...for my sanity

RCE Price at posting: $1.08 Sentiment: Buy Disclosure: Held
6 Upvote

0 Great analysis

Reply

Top Stories

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

RMX

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

MVF

Monash IVF shares cater 25% – Disaster or deep-value play?

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

First 1200 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 31.0¢		Change 0.010(3.33%)		Mkt cap ! $89.39M

Open	High	Low	Value	Volume
31.0¢	32.0¢	30.0¢	$25.76K	82.29K

Buyers (Bids)

No.	Vol.	Price($)
2	13550	30.0¢

Sellers (Offers)

Price($)	Vol.	No.
31.0¢	18938	1

View Market Depth

No.	Vol.	Price($)
2	13550	0.300
2	34803	0.295
2	50000	0.290
4	131061	0.285
10	251389	0.280

Price($)	Vol.	No.
0.310	18938	1
0.320	5000	1
0.325	12600	1
0.330	114230	1
0.350	51319	4

Last trade - 16.10pm 27/06/2025 (20 minute delay)

RCE (ASX) Chart

RCE Charts, page-1200

Australia’s gas crisis is here – and dying coal plants aren’t helping

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Monash IVF shares cater 25% – Disaster or deep-value play?

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

RCE Charts, page-1200

Top Stories

Australia’s gas crisis is here – and dying coal plants aren’t helping

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Monash IVF shares cater 25% – Disaster or deep-value play?

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News